# Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to 60 Months Suffering From Acute Diarrhea

> **NCT03473561** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 31 (actual)

## Conditions studied

- Diarrhea, Infantile

## Interventions

- **DRUG:** Racecadotril plus ORS

## Key facts

- **NCT ID:** NCT03473561
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-25
- **Primary completion:** 2020-01-08
- **Final completion:** 2020-01-08
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2023-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03473561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03473561, "Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to 60 Months Suffering From Acute Diarrhea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03473561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*